AI assistant
GEORGIA CAPITAL PLC — Director's Dealing 2018
Jun 1, 2018
5002_dirs_2018-06-01_e4c258dd-eea1-4d3c-89f4-3c7e23a04540.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 9312P
Georgia Capital PLC
01 June 2018
London, 31 May 2018
NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS
The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.
1.
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Ekaterina Shavgulidze
2.
Reason for the notification
a)
Position / status
PDMR, Chief Investment Officer
b)
Initial notification / amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Georgia Capital PLC
b)
LEI:
213800Q65T5GNBOW7H65
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification Code
ordinary shares of £0.01 each in Georgia Capital PLC
GB00BF4HYV08
b)
Nature of the transaction
Purchase of ordinary shares
c)
Price(s) and volume(s)
| Date | Price(s) | Volume(s) |
| 31 May 2018 | £10.00 | £24,500 |
d)
Aggregated information
Aggregated volume
2,450
Aggregated price
The aggregated volume price is £24,500.
e)
Date of the transaction
31 May 2018
f)
Place of the transaction
London Stock Exchange (XLON)
Name of authorised official of issuer responsible for making notification:
Rebecca Wooldridge, Company Secretary
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHDFLFXVEFXBBX